Astellas Pharma Inc. (ALPMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Core Perspective - Astellas Pharma expresses strong confidence in its long-term growth trajectory and aims to share its excitement and momentum with stakeholders [1] Group 1: Company Vision and Strategy - Astellas Pharma has a clear vision to transform innovative science into VALUE for patients, defined as outcomes that matter to patients divided by the costs to the entire healthcare system [2] - The company emphasizes the importance of creating better patient outcomes while managing healthcare costs across the system, rather than focusing solely on its own costs [2]